Logo image of DCGO

DOCGO INC (DCGO) Stock Fundamental Analysis

NASDAQ:DCGO - US2560861096 - Common Stock

1.62 USD
-0.03 (-1.82%)
Last: 8/27/2025, 8:00:01 PM
1.62 USD
0 (0%)
After Hours: 8/27/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, DCGO scores 3 out of 10 in our fundamental rating. DCGO was compared to 101 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DCGO had negative earnings in the past year.
DCGO had a positive operating cash flow in the past year.
DCGO had positive earnings in 4 of the past 5 years.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of DCGO (-4.49%) is worse than 66.34% of its industry peers.
DCGO has a Return On Equity of -6.16%. This is comparable to the rest of the industry: DCGO outperforms 43.56% of its industry peers.
Industry RankSector Rank
ROA -4.49%
ROE -6.16%
ROIC N/A
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

DCGO's Profit Margin has declined in the last couple of years.
DCGO's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 33.65%, DCGO is doing good in the industry, outperforming 66.34% of the companies in the same industry.
DCGO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.65%
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
Compared to 1 year ago, DCGO has a worse debt to assets ratio.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.03 indicates that DCGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
DCGO has a Altman-Z score of 2.03. This is comparable to the rest of the industry: DCGO outperforms 50.49% of its industry peers.
DCGO has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
DCGO's Debt to FCF ratio of 0.58 is amongst the best of the industry. DCGO outperforms 91.09% of its industry peers.
DCGO has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, DCGO is doing good in the industry, outperforming 72.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.58
Altman-Z 2.03
ROIC/WACCN/A
WACC8.26%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.36 indicates that DCGO has no problem at all paying its short term obligations.
The Current ratio of DCGO (2.36) is better than 80.20% of its industry peers.
A Quick Ratio of 2.36 indicates that DCGO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.36, DCGO belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 2.36
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for DCGO have decreased strongly by -137.93% in the last year.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.31%.
Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 24.60% on average per year.
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%

3.2 Future

DCGO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.69% yearly.
The Revenue is expected to decrease by -17.73% on average over the next years. This is quite bad
EPS Next Y-259.54%
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue Next Year-49.13%
Revenue Next 2Y-28.85%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DCGO. In the last year negative earnings were reported.
Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, DCGO is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.95
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A cheap valuation may be justified as DCGO's earnings are expected to decrease with -39.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DCGO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOCGO INC

NASDAQ:DCGO (8/27/2025, 8:00:01 PM)

After market: 1.62 0 (0%)

1.62

-0.03 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners54.74%
Inst Owner Change-12.74%
Ins Owners6.91%
Ins Owner Change4.5%
Market Cap158.45M
Analysts78.46
Price Target3.14 (93.83%)
Short Float %5.05%
Short Ratio7.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.06%
Min EPS beat(2)-311.74%
Max EPS beat(2)-14.37%
EPS beat(4)1
Avg EPS beat(4)-86.11%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-48.05%
EPS beat(12)3
Avg EPS beat(12)-63.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.48%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)0.77%
Revenue beat(12)7
Avg Revenue beat(12)1.29%
Revenue beat(16)10
Avg Revenue beat(16)9.13%
PT rev (1m)0.82%
PT rev (3m)-39.11%
EPS NQ rev (1m)-84.07%
EPS NQ rev (3m)-553.32%
EPS NY rev (1m)-19.61%
EPS NY rev (3m)-559.43%
Revenue NQ rev (1m)2.79%
Revenue NQ rev (3m)-31.14%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF 1.95
P/OCF 1.82
P/B 0.53
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)0.83
FCFY51.32%
OCF(TTM)0.89
OCFY55.02%
SpS4.46
BVpS3.04
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.49%
ROE -6.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.65%
FCFM 18.65%
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr 38.46%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.36
Quick Ratio 2.36
Altman-Z 2.03
F-Score5
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
EPS Next Y-259.54%
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
Revenue Next Year-49.13%
Revenue Next 2Y-28.85%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
EBIT growth 1Y-153.15%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-157.05%
EBIT Next 3Y-27.25%
EBIT Next 5YN/A
FCF growth 1Y457.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y734.5%
OCF growth 3YN/A
OCF growth 5YN/A